BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10861509)

  • 1. Patterns of chromosomal imbalances in invasive breast cancer.
    Richard F; Pacyna-Gengelbach M; Schlüns K; Fleige B; Winzer KJ; Szymas J; Dietel M; Petersen I; Schwendel A
    Int J Cancer; 2000 May; 89(3):305-10. PubMed ID: 10861509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung.
    Petersen S; Aninat-Meyer M; Schlüns K; Gellert K; Dietel M; Petersen I
    Br J Cancer; 2000 Jan; 82(1):65-73. PubMed ID: 10638968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
    Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P
    Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization.
    Günther K; Merkelbach-Bruse S; Amo-Takyi BK; Handt S; Schröder W; Tietze L
    J Pathol; 2001 Jan; 193(1):40-7. PubMed ID: 11169514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.
    Aldaz CM; Chen T; Sahin A; Cunningham J; Bondy M
    Cancer Res; 1995 Sep; 55(18):3976-81. PubMed ID: 7664266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.
    Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Welzl G; Höfler H; Werner M
    Int J Cancer; 2000 Jan; 85(1):82-6. PubMed ID: 10585588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetics of primary breast cancer by CGH.
    Tirkkonen M; Tanner M; Karhu R; Kallioniemi A; Isola J; Kallioniemi OP
    Genes Chromosomes Cancer; 1998 Mar; 21(3):177-84. PubMed ID: 9523192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer in young women (< or = 35 years): Genomic aberrations detected by comparative genomic hybridization.
    Weber-Mangal S; Sinn HP; Popp S; Klaes R; Emig R; Bentz M; Mansmann U; Bastert G; Bartram CR; Jauch A
    Int J Cancer; 2003 Nov; 107(4):583-92. PubMed ID: 14520696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.
    Loo LW; Grove DI; Williams EM; Neal CL; Cousens LA; Schubert EL; Holcomb IN; Massa HF; Glogovac J; Li CI; Malone KE; Daling JR; Delrow JJ; Trask BJ; Hsu L; Porter PL
    Cancer Res; 2004 Dec; 64(23):8541-9. PubMed ID: 15574760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes.
    Vanden Bempt I; Vanhentenrijk V; Drijkoningen M; De Wolf-Peeters C
    J Pathol; 2006 Mar; 208(4):486-94. PubMed ID: 16402338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
    Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
    Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.
    Hauptmann S; Denkert C; Koch I; Petersen S; Schlüns K; Reles A; Dietel M; Petersen I
    Hum Pathol; 2002 Jun; 33(6):632-41. PubMed ID: 12152163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
    Buerger H; Otterbach F; Simon R; Poremba C; Diallo R; Decker T; Riethdorf L; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W
    J Pathol; 1999 Mar; 187(4):396-402. PubMed ID: 10398097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
    Xu S; Wei B; Zhang H; Qing M; Bu H
    Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.
    Walch AK; Zitzelsberger HF; Bruch J; Keller G; Angermeier D; Aubele MM; Mueller J; Stein H; Braselmann H; Siewert JR; Höfler H; Werner M
    Am J Pathol; 2000 Feb; 156(2):555-66. PubMed ID: 10666385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q.
    Schwendel A; Richard F; Langreck H; Kaufmann O; Lage H; Winzer KJ; Petersen I; Dietel M
    Br J Cancer; 1998 Sep; 78(6):806-11. PubMed ID: 9743305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
    Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
    Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.
    Loo LW; Ton C; Wang YW; Grove DI; Bouzek H; Vartanian N; Lin MG; Yuan X; Lawton TL; Daling JR; Malone KE; Li CI; Hsu L; Porter PL
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1049-66. PubMed ID: 18720524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.